Details of the Drug

General Information of Drug (ID: DMNJT7Y)

• Drug Name: AL-60371

Indication

Disease Entry	ICD 11	Status	REF
Small-cell lung cancer	2C25.Y	Phase 3	[1]

• Cross-matching ID:
  PubChem CID: 11567473
  TTD ID: D0O5XQ

References

• [1] ClinicalTrials.gov (NCT01535560) Safety and Efficacy Evaluation of Topical AL-60371 Otic Suspension, 0.3% in the Treatment of Acute Otitis Externa. U.S. National Institutes of Health.